Evaluation of the MTS™ aztreonam-avibactam strip (Liofilchem) on New Delhi metallo-β-lactamase-producing Enterobacterales

Eur J Clin Microbiol Infect Dis. 2024 Apr;43(4):777-784. doi: 10.1007/s10096-024-04766-2. Epub 2024 Jan 26.

Abstract

The combination of ceftazidime-avibactam (CAZ-AVI) and aztreonam (ATM) is used to treat MBL-producing Enterobacterales-related infections. The new combination aztreonam-avibactam (AZA) is currently in development. We compared results obtained with the new MIC test strip (MTS) AZA (Liofilchem) with broth microdilution method (BMD) on 41 MBL-producing Enterobacterales from 41 clinical samples. The MTS AZA was also compared to combination testing method using CAZ-AVI and ATM strips. Compared to BMD, categorical agreement (CA) was 100%. Compared with combination testing method, CA was 97.6%. The MTS AZA can be used to determine MICs levels of AZA or CAZ-AVI/ATM combinations.

Keywords: Aztreonam-avibactam; Carbapenemase; Enterobacterales; Strip.

MeSH terms

  • Anti-Bacterial Agents* / pharmacology
  • Anti-Bacterial Agents* / therapeutic use
  • Azabicyclo Compounds*
  • Aztreonam* / pharmacology
  • Ceftazidime / therapeutic use
  • Drug Combinations
  • Humans
  • Microbial Sensitivity Tests
  • beta-Lactamases

Substances

  • Aztreonam
  • Anti-Bacterial Agents
  • beta-lactamase NDM-1
  • avibactam
  • Ceftazidime
  • beta-Lactamases
  • Drug Combinations
  • Azabicyclo Compounds